Heart Failure

Your daily dose of the clinical news you may have missed.

ACC.24: Results of STEP HFpEF DM showed significant improvement in quality of life measures among adults with obesity-related HFpEF and type 2 diabetes.

The Low EF AI is designed to detect low ejection fraction in 15 seconds during a primary care exam.

ACC.24: Data showed that individuals who used e-cigarettes were approximately 19% more likely to develop heart failure compared with those who had never vaped.

Your daily dose of the clinical news you may have missed.

The novel SGLT-2/SGLT-1 inhibitor reduced risk of stroke, MI, and demonstrates significant antiplatelet activity in post-hoc analyses of SCORED phase 3 trial.

New research highlights another benefit of COVID-19 vaccination, reported researchers.

The risk of severe CV events, including leading to death, was greatest in the first week following an exacerbation but remained significantly elevated 1 year later.

Uptitration of renin-angiotensin-aldosterone system inhibitors was less successful in women with acute heart failure, and particularly those with heart failure with reduced ejection fraction.

Semaglutide treatment reduced weight and was associated with greater, more consistent improvements in HFpEF than other recently studied drug classes.